CRDO Stock at $165: Buy, Sell, or Hold?
CRDO shed 20% in a single session despite its eighth straight earnings beat, with 18 of 19 analysts rating it a Buy.
CRDO outpaces SPY 44% to 12% year to date, but its top two customers represent 61% of revenue, amplifying any hyperscaler capex risk.
Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now. The report is free. Enter your email and see if any of your stocks made the cut.
At $164.52, Credo ( NASDAQ:CRDO ) looks compelling after the sell-off. The stock just shed 20.38% in a single session after posting a clean earnings beat, and that gap between fundamentals and price is where the opportunity lives.
Credo is a fabless semiconductor company selling high-speed connectivity into AI data centers. Its portfolio spans Active Electrical Cables, optical DSPs, retimers, silicon photonics, and the ZeroFlap, OmniConnect, and PILOT platforms. Hyperscalers are the buyers, and the company sits at a specific chokepoint of AI infrastructure: reliably moving data between GPUs, switches, and memory at 200 gig and 1.6T speeds.
Q1 FY2027 revenue hit $479 million, up 114.73% year over year, and non-GAAP EPS of $1.20 extended the beat streak to eight consecutive quarters. Yet shares gapped down hard. That reaction is the article.
Management guided Q2 revenue to $525 million to $535 million and told investors on the call that full-year FY2027 revenue should grow more than 85% year over year, with non-GAAP net margin in the vicinity of 50%. Optical alone is guided to exceed $600 million.
Valuation compresses fast against that math. Forward PE now sits near 41, well off the trailing multiple of 90. Non-GAAP gross margin held at 68% and non-GAAP operating margin at 48.2%. Wall Street's average target of $283.23 implies roughly 72% upside, and 18 of 19 covering analysts rate it Buy or Strong Buy.
It is an uncomfortable question, and there is now an answer to it.
24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.
Open your account and look at what you own. Some of it you bought for a reason you could still defend today. Some of it you bought years ago for a reason you can no longer remember.
The report is free. Put the ten next to what you own and find out which is which.
Customer concentration is severe. The top four customers each represented at least 10% of revenue, with the largest at 33% and the second at 28%. Any hyperscaler capex hiccup lands directly on Credo's income statement.
The Dust Photonics deal added complexity. Goodwill jumped from $92.8 million to $986.4 million, GAAP gross margin slipped to 64.5% from 68.2% sequentially, and quarterly share-based comp ran at $87.98 million. Price-to-sales of 32 leaves no margin for a demand air pocket, and a beta of 3.233 guarantees more days like this one.
Bulls need FY2028 optical ramps and OmniConnect design wins to actually convert. Management targets ALC revenue in fiscal 2028 and first OmniConnect revenue in fiscal 2028. Until those show up in reported numbers, skeptics can argue the guide is aspirational.
Post-earnings volatility supports the wait-and-see camp. Q3 FY2026 also produced a beat with a -14.81% day-of drop, and Q2 FY2026 followed a beat with a -25.58% thirty-day slide. Waiting for the dust to settle and buying above the 200-day moving average of $174.78 is a defensible plan.
Credo currently trades at $164.52, sitting well below the average analyst target of $283.23 drawn from 19 analysts. Coverage skews bullish, with 4 Strong Buy, 14 Buy, 1 Hold, and 0 Sell ratings. Targets are not guarantees, and the gap partly reflects analyst estimates that have not been updated for today's move.
Even after the drop, CRDO is up 43.6% year to date and 67.92% over the past year, versus SPY at 11.71% and 18.1%. Valuation remains rich at 32 times sales, but forward earnings expectations reset the multiple meaningfully.
At $164.52, the setup for Credo looks constructive. Here is why.
The path to appreciation runs through three visible catalysts inside the next 12 months. First, the Q2 print near $530 million confirms sequential growth.
Second, first 1.6T DSP revenue and ZeroFlap ramps hit later in FY2027, with optics guided to exceed $600 million.
Third, initial OmniConnect and ALC revenue arrive in FY2028, opening what management calls multi-billion dollar TAM opportunities.
Risk-reward at this entry is asymmetric. A forward PE near 41 against 85%-plus revenue growth and 50% net margins is not cheap, but it is defensible. The 20% flush likely reflected profit-taking, elevated expectations after a run to $308.67, and a modest revenue-beat magnitude of only 1.83% rather than any deterioration in the business.
The thesis breaks if hyperscaler capex rolls over, if the top-two customers pull orders, or if optical ramps slip past FY2028. Investors should watch quarterly customer concentration disclosures, the trajectory of optical revenue toward the $600 million annual bar, and inventory, which climbed $62.2 million sequentially to $313.1 million.
Buying a compounding AI-connectivity leader at a 20.38% single-day discount, with eight straight beats and a guided doubling of the optical business, is a scenario worth researching at this price.
If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today.
Contact editorial@247wallst.com for any questions or corrections.
